Sheng Yu
Southern Medical University
7 Papers
Sheng Yu is an academic researcher from Southern Medical University. The author has contributed to research in topics: Internal medicine & Hepatocyte. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Ceramides and sphingosine-1-phosphate mediate the distinct effects of M1/M2-macrophage infusion on liver recovery after hepatectomy.
Hang Sun,Shibo Sun,Gang Chen,Haorong Xie,Haorong Xie,Sheng Yu,Xinxin Lin,Jianping Qian,Cungui Mao,Hongxian Peng,Hao Chen,Xuefang Chen,Xuefang Chen,Yiyi Li,Cuiting Liu,Junmin Shi,Bili Zhu,Linghong Guo,Qingping Li,Pengxiang Huang,Yiran Wei,Xixin Huang,Meiqi Liu,Zhonglin Cui,Qifan Zhang,Jie Zhou,Chuanjiang Li,Kai Wang +27 more
TL;DR: In this article, the key bioactive lipids that mediate the cytotherapeutic potential of polarized-macrophage for post-hepatectomy liver dysfunction were investigated.
Pre-transplant Use of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: A Multicenter, Retrospective Cohort Study.
Z. Guo,Yao Liu,Qi ling,Leibo Xu,Tielong Wang,Jiaxing Zhu,Yimou Lin,Xinjun Lu,Wei Qu,Zhijun Zhu,Ping Zeng,Wenjing Wang,Qiang Sun,Qijie Luo,Zemin Hu,Zhouying Zheng,Yingbin Jia,Jian Li,Yujian Zheng,Shao-ping Wang,Zemin Han,Sheng Yu,Chuanjiang Li,Shuhua Zhang,Jun Xiong,Feiwen Deng,Yanfeng Wang,Wenjin Liang,Andrea Schlegel,Nashan Björn,Shusen Zheng,Xiaoshun He +31 more
TL;DR: Patients who receive a pre-LT ICIs therapy with a TLAT shorter than 30 days have a much higher risk of allograft rejection than those with a TLAT longer than 30 days.
Resveratrol Reduced Liver Damage After Liver Resection in a Rat Model by Upregulating Sirtuin 1 (SIRT1) and Inhibiting the Acetylation of High Mobility Group Box 1 (HMGB1).
TL;DR: Resveratrol reduced postoperative liver injury as shown by reduced ALT, AST, γ-GT, and total bilirubin levels, maintained liver structure, and reduced cell apoptosis.
Targeting the ceramidase ACER3 attenuates cholestasis in mice by mitigating bile acid overload via unsaturated ceramide-mediated LXRβ signaling transduction
Le-Tai Liao,Ziying Liu,Lei Liu,Can Huang,Yiyi Li,Cungui Mao,Haiqing Liu,Cuiting Liu,Yonghong Peng,Tingying Lei,Hanbiao Liang,Sheng Yu,Jian-ping Qian,Xianqiu Wu,Biao Wang,Yixiong Lin,Jie Zhou,Qingping Li,Chuanjiang Li,Kai Wang +19 more
TL;DR: Targeting ACER3, a ceramidase upregulated in cholestatic liver, alleviates liver injury in mice by enhancing bile acid sulfation via unsaturated ceramide-activated LXRβ signaling, reducing bile acid overload and mitigating cholestatic liver injury.
LINC00265 maintains hepatocyte proliferation during liver regeneration by targeting miRNA-28-5p.
TL;DR: Li et al. as mentioned in this paper investigated the role of LINC00265 as a pivotal regulator of hepatocyte proliferation during liver regeneration and found that LINC 00265 is significantly upregulated in rat liver tissues at various time points after 2/3 liver resection.